SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-20-000557
Filing Date
2020-02-06
Accepted
2020-02-07 13:33:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 167560
  Complete submission text file 9999999997-20-000557.txt   231888
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SEC STAFF LETTER
SIC: 2834 Pharmaceutical Preparations